Literature DB >> 2293210

Nebulization of liposomes. I. Effects of lipid composition.

R W Niven1, H Schreier.   

Abstract

A series of multilamellar liposome dispersions was prepared from lipids of soy phosphatidylcholine or hydrogenated soy phosphatidylcholine containing from 0 to 30 mol% of either cholesterol, stearylamine, or dipalmitoyl phosphatidylglycerol. The liposome dispersions were aerosolized with a Collison nebulizer for 80 min at an output flow rate of 4.7 liters of air/min. The effects of nebulization on the vesicles were determined by monitoring the release of encapsulated 5,6-carboxylfluorescein (CF) from dispersions containing approximately 200 micrograms of total CF, of which 93.1 +/- 2.4% (N = 18) was initially encapsulated. In all experiments CF was released from the liposomes while being aerosolized, and this ranged from a mean of 12.7 +/- 3.8 to 60.9 +/- 1.9% of the encapsulated CF, depending upon the lipid composition. The lipid concentration in the dispersions did not affect the rate or percentage release of CF over a range of approximately 0.5 to 50 mg per nebulized dispersion. If liposomes are to be used as drug carriers in an inhalation aerosol a lipid composition should be employed which will minimize the release of encapsulated drug caused by nebulization.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2293210     DOI: 10.1023/a:1015924124180

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  23 in total

1.  Stabilization of lipid bilayer vesicles by sucrose during freezing.

Authors:  G Strauss; H Hauser
Journal:  Proc Natl Acad Sci U S A       Date:  1986-04       Impact factor: 11.205

2.  Lipid composition and permeability of liposomes.

Authors:  J de Gier; J G Mandersloot; L L van Deenen
Journal:  Biochim Biophys Acta       Date:  1968-06-11

3.  Two dimensional then layer chromatographic separation of polar lipids and determination of phospholipids by phosphorus analysis of spots.

Authors:  G Rouser; S Fkeischer; A Yamamoto
Journal:  Lipids       Date:  1970-05       Impact factor: 1.880

4.  Problems patients have using pressurized aerosol inhalers.

Authors:  G K Crompton
Journal:  Eur J Respir Dis Suppl       Date:  1982

5.  The influence of liposomal encapsulation on sodium cromoglycate pharmacokinetics in man.

Authors:  K M Taylor; G Taylor; I W Kellaway; J Stevens
Journal:  Pharm Res       Date:  1989-07       Impact factor: 4.200

6.  Toxicity of non-drug-containing liposomes for cultured human cells.

Authors:  E Mayhew; M Ito; R Lazo
Journal:  Exp Cell Res       Date:  1987-07       Impact factor: 3.905

7.  A calorimetry and deuterium NMR study of mixed model membranes of 1-palmitoyl-2-oleylphosphatidylcholine and saturated phosphatidylcholines.

Authors:  W Curatolo; B Sears; L J Neuringer
Journal:  Biochim Biophys Acta       Date:  1985-07-25

8.  Clearance of phosphatidylcholine and cholesterol from liposomes, liposomes loaded with metaproterenol, and rabbit surfactant from adult rabbit lungs.

Authors:  A Pettenazzo; A Jobe; M Ikegami; R Abra; E Hogue; P Mihalko
Journal:  Am Rev Respir Dis       Date:  1989-03

9.  The influence of membrane composition on the solubilizing effects of Triton X-100.

Authors:  M A Urbaneja; J L Nieva; F M Goñi; A Alonso
Journal:  Biochim Biophys Acta       Date:  1987-11-13

10.  Small particle aerosols of enviroxime-containing liposomes.

Authors:  B E Gilbert; H R Six; S Z Wilson; P R Wyde; V Knight
Journal:  Antiviral Res       Date:  1988-09       Impact factor: 5.970

View more
  16 in total

Review 1.  Pulmonary drug delivery. Part II: the role of inhalant delivery devices and drug formulations in therapeutic effectiveness of aerosolized medications.

Authors:  N R Labiris; M B Dolovich
Journal:  Br J Clin Pharmacol       Date:  2003-12       Impact factor: 4.335

2.  Nebulization of liposomes. II. The effects of size and modeling of solute release profiles.

Authors:  R W Niven; M Speer; H Schreier
Journal:  Pharm Res       Date:  1991-02       Impact factor: 4.200

Review 3.  Carrier-based strategies for targeting protein and peptide drugs to the lungs.

Authors:  Sally-Ann Cryan
Journal:  AAPS J       Date:  2005-03-24       Impact factor: 4.009

4.  Iloprost-containing liposomes for aerosol application in pulmonary arterial hypertension: formulation aspects and stability.

Authors:  Elke Kleemann; Thomas Schmehl; Tobias Gessler; Udo Bakowsky; Thomas Kissel; Werner Seeger
Journal:  Pharm Res       Date:  2006-12-27       Impact factor: 4.200

5.  The effect of liposome encapsulation on the pharmacokinetics of recombinant secretory leukocyte protease inhibitor (rSLPI) therapy after local delivery to a guinea pig asthma model.

Authors:  Aileen Gibbons; Danielle Padilla-Carlin; Ciara Kelly; Anthony J Hickey; Clifford Taggart; Noel G McElvaney; Sally-Ann Cryan
Journal:  Pharm Res       Date:  2011-06-07       Impact factor: 4.200

6.  Nebulization of Cyclic Arginine-Glycine-(D)-Aspartic Acid-Peptide Grafted and Drug Encapsulated Liposomes for Inhibition of Acute Lung Injury.

Authors:  Hari R Desu; Laura A Thoma; George C Wood
Journal:  Pharm Res       Date:  2018-03-13       Impact factor: 4.200

7.  Aerosol-stable peptide-coated liposome nanoparticles: a proof-of-concept study with opioid fentanyl in enhancing analgesic effects and reducing plasma drug exposure.

Authors:  John D Hoekman; Pramod Srivastava; Rodney J Y Ho
Journal:  J Pharm Sci       Date:  2014-06-06       Impact factor: 3.534

8.  A dry powder formulation of liposome-encapsulated recombinant secretory leukocyte protease inhibitor (rSLPI) for inhalation: preparation and characterisation.

Authors:  Aileen Gibbons; Noel G McElvaney; Sally-Ann Cryan
Journal:  AAPS PharmSciTech       Date:  2010-09-15       Impact factor: 3.246

9.  Unilamellar vesicles as potential capreomycin sulfate carriers: preparation and physicochemical characterization.

Authors:  Stefano Giovagnoli; Paolo Blasi; Claudia Vescovi; Giuseppe Fardella; Ione Chiappini; Luana Perioli; Maurizio Ricci; Carlo Rossi
Journal:  AAPS PharmSciTech       Date:  2004-12-31       Impact factor: 3.246

10.  Nebulization of liposomes. III. The effects of operating conditions and local environment.

Authors:  R W Niven; T M Carvajal; H Schreier
Journal:  Pharm Res       Date:  1992-04       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.